Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report.

Shimizu, Hideyasu; Kato, Hisayuki; Yoshioka, Satoshi; Okazawa, Mitsushi

Shimizu, Hideyasu; Kato, Hisayuki; Yoshioka, Satoshi; Okazawa, Mitsushi.

Afiliação

Shimizu H; Toshiwakai Clinic, Nagoya Japan, Nagoya, Japan.
Kato H; Department of Medicine, Division of Respiratory Medicine and Clinical Allergy, Fujita Health University, Toyoake, Japan.
Yoshioka S; Department of Otolaryngology-Head and Neck Surgery, Fujita Health University, Toyoake, Japan.
Okazawa M; Department of Otolaryngology-Head and Neck Surgery, Fujita Health University, Toyoake, Japan.

Respir Med Case Rep ; 32: 101336, 2021.

Article em En | MEDLINE | ID: mdl-33489745

Palavras-chave

ADL, activity of daily living; AR, allergic rhinitis; BMI, body mass index; Benralizumab; CT, computed tomography; ECRS, eosinophilic chronic rhinosinusitis; EOM, eosinophilic otitis media; Eosinophilic chronic rhinosinusitis; Eosinophilic otitis media; FeNO, Fractional exhaled nitric oxide; JESREC, Japanese epidemiological survey of refractory eosinophilic rhinosinusitis; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroids; QOL; QOL, quality of life; SMART, single maintenance and reliever therapy; Severe asthma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Respir Med Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google